Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2+ Breast Cancer
Interventions: DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Nab paclitaxel|DRUG: Pyrotinib|DRUG: Capecitabine|DRUG: T-DM1|DRUG: Everolimus|DRUG: CDK4/6 inhibitor|DRUG: AI|DRUG: Anti-PD-1 monoclonal antibody
Sponsor: First Affiliated Hospital Xi'an Jiaotong University